Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets

A rapid, sensitive, and reproducible reverse phase high performance liquid chromatographic (RP-HPLC) method with UV detector for the determination of nimodipine in sustained release tablets was developed. The method involved using a SinoChoom ODS-BP C18 reversed phase column (5 μm, 4.6 mm × 200 mm)...

Full description

Bibliographic Details
Main Authors: Xiaojun Shang, Suying Ma, Zheshen Li
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2013/612082
id doaj-cb55d4e55d9247a29f93b8aea6fd7284
record_format Article
spelling doaj-cb55d4e55d9247a29f93b8aea6fd72842020-11-24T21:30:48ZengHindawi LimitedJournal of Chemistry2090-90632090-90712013-01-01201310.1155/2013/612082612082Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release TabletsXiaojun Shang0Suying Ma1Zheshen Li2School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, ChinaSchool of Pharmacy, Xinxiang Medical University, Xinxiang 453003, ChinaSchool of Pharmacy, Xinxiang Medical University, Xinxiang 453003, ChinaA rapid, sensitive, and reproducible reverse phase high performance liquid chromatographic (RP-HPLC) method with UV detector for the determination of nimodipine in sustained release tablets was developed. The method involved using a SinoChoom ODS-BP C18 reversed phase column (5 μm, 4.6 mm × 200 mm) and mobile phase consisting of methanol-acetonitrile-water (35 : 38 : 27, v/v). The flow rate is 1.0 mL/min, the UV detector was operated at 237 nm, and the column was maintained at 25°C. The method was validated according to official compendia guidelines. The calibration curve of nimodipine for RP-HPLC method was linear over the range of 10–100 μg/mL. The retention time was found at 7.50 min for nimodipine. The variation for interday and intraday assay was found to be less than 0.72%. The proposed RP-HPLC was proved to be suitable for the determination of nimodipine in sustained release tablets.http://dx.doi.org/10.1155/2013/612082
collection DOAJ
language English
format Article
sources DOAJ
author Xiaojun Shang
Suying Ma
Zheshen Li
spellingShingle Xiaojun Shang
Suying Ma
Zheshen Li
Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets
Journal of Chemistry
author_facet Xiaojun Shang
Suying Ma
Zheshen Li
author_sort Xiaojun Shang
title Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets
title_short Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets
title_full Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets
title_fullStr Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets
title_full_unstemmed Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets
title_sort development and validation of a rp-hplc method for determination of nimodipine in sustained release tablets
publisher Hindawi Limited
series Journal of Chemistry
issn 2090-9063
2090-9071
publishDate 2013-01-01
description A rapid, sensitive, and reproducible reverse phase high performance liquid chromatographic (RP-HPLC) method with UV detector for the determination of nimodipine in sustained release tablets was developed. The method involved using a SinoChoom ODS-BP C18 reversed phase column (5 μm, 4.6 mm × 200 mm) and mobile phase consisting of methanol-acetonitrile-water (35 : 38 : 27, v/v). The flow rate is 1.0 mL/min, the UV detector was operated at 237 nm, and the column was maintained at 25°C. The method was validated according to official compendia guidelines. The calibration curve of nimodipine for RP-HPLC method was linear over the range of 10–100 μg/mL. The retention time was found at 7.50 min for nimodipine. The variation for interday and intraday assay was found to be less than 0.72%. The proposed RP-HPLC was proved to be suitable for the determination of nimodipine in sustained release tablets.
url http://dx.doi.org/10.1155/2013/612082
work_keys_str_mv AT xiaojunshang developmentandvalidationofarphplcmethodfordeterminationofnimodipineinsustainedreleasetablets
AT suyingma developmentandvalidationofarphplcmethodfordeterminationofnimodipineinsustainedreleasetablets
AT zheshenli developmentandvalidationofarphplcmethodfordeterminationofnimodipineinsustainedreleasetablets
_version_ 1725961695025692672